Altre lingue 2seventy bio, Inc.

Azioni

TSVT

US9013841070

Tempo reale stimato Cboe BZX Altri mercati azionari 16:12:02 24/04/2024			Variaz. 5gg	Var. 1 gen.
4,445 ^USD	-4,00%		-11,46%	+4,92%

05/04	Bristol-Myers Squibb, 2seventy Bio dichiarano che la FDA approva l'espansione dell'indicazione del trattamento del mieloma	MT
05/04	La FDA statunitense autorizza l'uso esteso della terapia cellulare di Bristol Myers per il cancro del sangue	RE

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

US FDA mandates label updates on CAR-T cancer therapies	19/04
FDA Approves BMS And J&J CAR-T Cell Therapies For The Earlier Treatment Of Multiple Myeloma	17/04
U.S. FDA Approves Bristol Myers Squibb and 2seventy bio's Abecma for Triple-Class Exposed Relapsed or Refractory Multiple Myeloma after Two Prior Lines of Therapy	08/04
Bristol-Myers Squibb, 2seventy Bio Say FDA Approves Expansion of Myeloma Treatment's Indication	05/04
Bristol Myers, 2seventy Get FDA OK for Earlier Abecma Use in Multiple Myeloma	05/04
Bristol Myers : la FDA valide Abecma dans le myélome multiple	05/04
US FDA allows expanded use of Bristol Myers' cell therapy for blood cancer	05/04
U.S. FDA allows expanded use of Bristol Myers' cell therapy	05/04
U.S. Fda Approves Bristol Myers Squibb and 2Seventy Bio?S Abecma for Triple-Class Exposed Relapsed or Refractory Multiple Myeloma After Two Prior Lines of Therapy	05/04
2seventy bio : Corporate Presentation April 2024	01/04
2seventy bio Announces Completion of Oncology and Autoimmune Pipeline Divestiture to Regeneron	01/04
Regeneron Pharmaceuticals, Inc. completed the acquiistion of R&D pipeline from 2seventy bio, Inc..	01/04
Regeneron Pharmaceuticals, Inc. completed the acquiistion of R&D pipeline from 2seventy bio, Inc. for $15 million.	01/04
Bristol Myers Squibb Gets EU OK for Cancer Treatment	20/03
Engine Capital Nominates Candidates to the Board of 2seventy bio	20/03
2seventy bio Announces Appointments of Eli Casdin and Charles Newton to Board of Directors	20/03
2seventy bio, Inc. Announces Board Appointments	20/03
Thinking about buying stock in Solidion Technology, Nuvei, 2Seventy Bio, Aeye, or DHC Acquisition?	18/03
Top Premarket Gainers	18/03
FDA Advisory Committee Votes in Favor of Bristol Myers Squibb's and 2seventy bio's Abecma for Triple-Class Exposed Multiple Myeloma in Earlier Lines of Therapy	18/03

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue 2seventy bio, Inc.

Azioni

TSVT

US9013841070

Altre lingue

Filtri